Literature DB >> 21970361

Positive and negative appraisals of the consequences of activated states uniquely relate to symptoms of hypomania and depression.

Rebecca E Kelly1, Warren Mansell, Vaneeta Sadhnani, Alex M Wood.   

Abstract

Individuals may appraise internal states positively or negatively. Positive appraisals involve desiring or pursuing the state or experience, while negative appraisals involve dreading or avoiding the experience. The extent to which individuals make extreme positive or negative appraisals of high, activated, energetic states might determine whether they experience symptoms of high or low mood. This study extends the existing literature by considering the role of opposing appraisals and beliefs about the same internal states and by controlling for the potential correlation between depression and activation symptoms. Extreme, positive and negative appraisals of activated mood states related distinctly to experiences of activation and depression symptoms respectively, in an analogue sample (n=323). Positive appraisals of activated internal states were uniquely associated with elevated activation and hypomania symptoms. Negative appraisals of the same states were uniquely associated with elevated depression symptoms. Opposing appraisals of internal states may underlie mood swing symptoms.

Entities:  

Mesh:

Year:  2011        PMID: 21970361     DOI: 10.1080/02699931.2011.613918

Source DB:  PubMed          Journal:  Cogn Emot        ISSN: 0269-9931


  2 in total

1.  Looking on the bright side and seeing it vividly: interpretation bias and involuntary mental imagery are related to risk for bipolar disorder.

Authors:  Andrew D Peckham; Kiana Modavi; Sheri L Johnson
Journal:  Behav Cogn Psychother       Date:  2019-10-10

Review 2.  "When my Moods Drive Upward There Is Nothing I Can Do about It": A Review of Extreme Appraisals of Internal States and the Bipolar Spectrum.

Authors:  Rebecca E Kelly; Alyson L Dodd; Warren Mansell
Journal:  Front Psychol       Date:  2017-08-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.